{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-007597","form_type":"8-K","ticker":"TERN","cik":"0001831363","company_name":"Terns Pharmaceuticals, Inc.","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.908670+00:00","generated_at":"2026-06-18T04:49:42.010412+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"medium","headline":"Terns Pharmaceuticals states no exposure to SVB failure; operations unaffected","bullets":["Cash equivalents and marketable securities held at multiple large financial institutions.","Cash balances in operating accounts also at multiple large banks, not concentrated at SVB.","Company does not expect any disruptions to operations, including payroll, from recent bank closures.","Forward-looking statements about sufficiency of cash resources."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-007597","json":"https://secwatch.observer/filing/0000950170-23-007597.json","markdown":"https://secwatch.observer/filing/0000950170-23-007597.md","text":"https://secwatch.observer/filing/0000950170-23-007597.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831363/000095017023007597/0000950170-23-007597-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831363/000095017023007597/tern-20230313.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:49:42.010412+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}